Investigation of a Patient Support Intervention for Statin Medication Adherence
A Randomized Trial of Gamification and Remote Support to Improve Statin Adherence
1 other identifier
interventional
2,200
1 country
1
Brief Summary
Statins have been demonstrated to significantly reduce the risk of cardiovascular disease, but adherence to these medications is suboptimal. Improving adherence can be challenging because it is multifactorial and behaviors often occur within the everyday lives of patients and are less addressable during a visit with a clinician. In this study, the investigators will conduct a randomized trial to evaluate a behaviorally-designed gamification intervention with remote nursing support to improve statin adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
March 30, 2026
March 1, 2026
11 months
May 7, 2025
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Statin adherence, population average
Statin adherence, measured using the proportion of days covered (PDC), during the 6-month intervention period
6-months after enrollment
Secondary Outcomes (1)
Statin adherence, proportion of population with PDC>=80%
6-months after enrollment
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants in the usual care arm will have consented for participation and will be informed they are on a waiting list for approximately 6-12 months. During that time they will receive no additional interventions beyond usual care and not be be invited again to enroll in the MedTrack program.
Text Message Group
EXPERIMENTALParticipants in the intervention arm will have consented for participation in the MedTrack program and will receive the text message intervention and remote support within 1-2 weeks of enrolling.
Interventions
Participants in the intervention arm consists of several components: (I) medication check-ins with the ability to set the time(s) for daily medication reminders, (II) a gamification experience to drive behavior change, (III) ability to identify a support partner who receives weekly updates on the patient's game status; (IV) access to an RN team for clinical questions and care coordination, and (V) patients' providers can see real-time progress within an electronic health record (EHR) integrated application.
Eligibility Criteria
You may qualify if:
- Adults, age 18 and older
- Have a phone or email on file to receive outreach to participate in the study
- Have a primary care provider (PCP) employed by Ascension.
- Prescribed a statin medication and had filled two statin prescriptions in the previous 12 months (one in the prior 6 months and another in the previous 6 to 12 months)
- PDC \<80% in the prior 12 months
- Have consented for electronic communications with Ascension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ascension Healthlead
- Brigham and Women's Hospitalcollaborator
Study Sites (1)
Ascension Health
St Louis, Missouri, 63134, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Clinical Transformation Officer
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 15, 2025
Study Start
April 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
The study has patient information that the investigators are not approved to share.